Exabis Library
Welcome to the e-CCO Library!
P358: Six-year adalimumab efficacy in steroid-dependent Crohn’s disease patients: a prospective ‘real-life’ study
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P358: Ustekinumab is effective for the treatment of chronic antibiotic-refractory pouchitis
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P359 Platelet-rich stroma injection (PRS) as a novel surgical treatment of refractory perianal fistulas in Crohn’s disease: A pilot study
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P359: A novel phase 1 trial design to evaluate safety, tolerability, pharmacokinetics, and pharmacodynamics of TOP1288, a narrow spectrum kinase inhibitor, delivered topically to the colon via oral administration
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P359: Budesonide MMX in paediatric ulcerative colitis
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P359: Correlation between physician and patient disease assessments in ulcerative colitis: baseline data from the ICONIC study of 1816 patients in 33 countries
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P359: Correlation of simple laboratory tests with clinical disease activity scores in inflammatory bowel disease
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P359: Evaluation of usability and performance of home fecal sampling using a dedicated device
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P359: Influence of the nature of immunosuppressive therapy in patients with inflammatory bowel diseases on the level of immunoglobulins G after a Coronavirus Infection
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P359: Radiomics could predict surgery at 10 years in Crohn’s disease
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P360 Safety and clinical efficacy of double switch from originator infliximab to biosimilars CT-P13 and SB2 in patients with inflammatory bowel diseases (SCESICS): A multicentre study
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P360: A randomised, assessor-blinded, multicentre trial comparing the efficacy, safety, and tolerability of a new tailored dosing regimen to day-before dosing regimen of colon cleansing agent used before colonoscopy
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P360: Aggressive Inflammatory Bowel Disease is associated to Hermansky-Pudlak Syndrome: Characterization of a Puerto Rican Cohort
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P360: Inflammatory microheterogeneity in ulcerative colitis: implications for microscopic assessment of disease activity
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P360: Role of intestinal ultrasound scores in the diagnosis of post-operative recurrence in Crohn's disease
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P360: The correlation between ophthalmological posterior segment findings and disease severity in patients with inflammatory bowel disease
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P360: Trough levels and antibodies to ustekinumab are not correlated to response to ustekinumab treatment in Crohn's disease patients
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P360: TrueColours ulcerative colitis (TCUC): Will patients with UC complete digital questionnaires in real-time?
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P361 The effect of immunomodulators and other factors on the persistence of biological agents for Crohn’s disease and ulcerative colitis: data from the Australian population-based registry
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P361: Adherence to faecal calprotectin test in patients with inflammatory bowel disease
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM